Fibroblast growth factor 21 (FGF21) has been recently identified as a novel metabolic regulator which plays a crucial role in glucose homeostasis, lipid metabolism, insulin sensitivity and obesity [1-3]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.